Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
about
Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancerHigh expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer.Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.The investigation of 125I seed implantation as a salvage modality for unresectable pancreatic carcinoma.The role of chemoradiation therapy in locally advanced pancreatic cancer.Lack of effectiveness of radiotherapy combined with cisplatin in patients with locally advanced pancreatic carcinoma.Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.Phase II trial of primary radiation therapy and concurrent chemotherapy for patients with locally advanced pancreatic cancer.Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of
P2860
Q33923018-22F77ED5-DB65-45D2-A871-363AE5F371F5Q34126942-147798CE-FD2E-4760-8142-FBCE4886B0C2Q36552512-9FA5264A-F3EB-4B7C-B96D-8A08E5620BB0Q36671593-D5F3C056-6542-43A0-AE5B-1CA5FC2E4A13Q37480071-CCC40077-EB2C-48DE-B63B-6DA5DC9E438EQ41842364-A7E321C3-4662-4310-AB02-0DF98F119144Q43563162-EB0F38CF-AEFF-41DE-89CD-A5D92D1A483FQ44199019-27C105A4-8F43-4518-BE57-821805E911B5Q46601912-831BE33E-5E37-4FD3-B0CD-644B80A2434AQ46604466-E3944882-8EDA-408B-93A9-24808CF5A068
P2860
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@ast
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@en
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@nl
type
label
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@ast
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@en
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@nl
prefLabel
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@ast
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@en
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@nl
P2093
P2860
P356
P1476
Treatment of unresectable, loc ...... cil, leucovorin and cisplatin.
@en
P2093
Marczell A
Scheithauer W
Schratter-Sehn A
P2860
P2888
P304
P356
10.1054/BJOC.1999.0884
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1009289617